Come up with a name for your new list and we'll add to it:
SphynKx Therapeutics raised a round of funding on September 23, 2013. Investors include
National Institutes of Health.
SphynKx Therapeutics is a privately held biotechnology company based in Charlottesville, VA. We are focused on discovering, developing, and commercializing novel sphingosine kinase (SphK) inhibitors f…